Porcine Spleen Extract (Sus scrofa domesticus)

Porcine spleen extract is a glandular supplement derived from pig spleen tissue containing bioactive peptides, tuftsin, and splenopentin that modulate immune function by activating natural killer cells and enhancing antibody synthesis. Its primary mechanism involves interaction with phagocyte receptors and cytokine regulation, particularly influencing TNF-α and IL-10 signaling pathways.

Category: Protein Evidence: 2/10 Tier: Emerging
Porcine Spleen Extract (Sus scrofa domesticus) — Hermetica Encyclopedia

Origin & History

Porcine spleen extract is derived from the spleen tissue of domestic pigs (Sus scrofa domesticus) through enzymatic hydrolysis or dialysis techniques to produce peptide hydrolysates and bioactive compounds. The extraction process typically involves proteolytic enzymes such as trypsin, α-chymotrypsin, and bacterial proteases to break down proteins into smaller peptide fragments, with the resulting product commonly spray-dried into powder form.

Historical & Cultural Context

No information regarding historical use in traditional medicine systems was identified in the available research. The extract appears to be a modern development utilizing enzymatic processing techniques.

Health Benefits

• May support immune system function through enhanced NK cell activity and antibody synthesis (animal studies only)
• Demonstrates antioxidant properties through radical scavenging activity (preliminary rat studies)
• Shows potential anti-inflammatory effects by reducing TNF-α/IL-10 ratios (mouse splenocyte studies)
• May promote immune organ development and increase intestinal sIgA levels (animal models)
• Could enhance survival in viral infection models (mouse herpes studies, PMID: 25867497)

How It Works

Porcine spleen extract contains tuftsin (Thr-Lys-Pro-Arg), a tetrapeptide that binds leukokinin receptors on macrophages and neutrophils to stimulate phagocytosis and NK cell cytotoxicity. Splenopentin, a pentapeptide fragment, modulates T-lymphocyte differentiation by interacting with thymic peptide receptors and influencing IL-2 production. Additional bioactive components exert antioxidant effects through free radical scavenging and may downregulate pro-inflammatory signaling by reducing TNF-α synthesis while supporting IL-10-mediated anti-inflammatory balance.

Scientific Research

Clinical evidence for porcine spleen extract is extremely limited, consisting primarily of animal studies with no published human randomized controlled trials identified. Mouse studies have shown increased survival in herpes infection models (PMID: 25867497), while rat studies demonstrated antioxidant activity without adverse effects on standard health parameters.

Clinical Summary

The evidence base for porcine spleen extract is largely preclinical, with most data derived from rodent models involving small sample sizes of 10–30 animals per group. Mouse studies have demonstrated statistically significant reductions in TNF-α/IL-10 ratios under inflammatory conditions, and rat studies show measurable radical scavenging activity comparable to reference antioxidants in vitro. Limited human clinical data exist; a small number of Eastern European clinical trials from the 1980s–1990s explored spleen hydrolysate preparations in immunocompromised patients, but these lacked rigorous placebo controls and modern reporting standards. Overall, evidence strength is low-to-preliminary, and robust randomized controlled trials in humans are absent.

Nutritional Profile

Porcine spleen extract is a protein-rich biological matrix derived from Sus scrofa domesticus spleen tissue. Protein content is typically high, estimated at 60–80% of dry weight, composed of a complex mixture of structural and functional proteins including globins, actin, myosin fragments, and immunologically active peptides such as tuftsin (Thr-Lys-Pro-Arg tetrapeptide) and splenopentin (Arg-Lys-Glu-Val-Tyr pentapeptide), which are the primary characterized bioactive compounds. Iron content is notably elevated due to the spleen's role in erythrocyte recycling and hemoglobin processing; total iron is estimated at 10–30 mg per 100g dry weight, predominantly as heme iron with high bioavailability (~25–30% absorption rate) alongside non-heme iron associated with ferritin and hemosiderin storage proteins. Zinc is present at approximately 3–6 mg per 100g dry weight, contributing to immune signaling. Copper is present in moderate concentrations (~0.5–1.5 mg per 100g), associated with ceruloplasmin-like proteins involved in iron metabolism. The extract contains B-vitamins, particularly vitamin B12 (estimated 2–5 µg per 100g dry weight) and riboflavin (B2, ~0.3–0.6 mg per 100g). Lipid content is relatively low (~5–10% dry weight) with phospholipids including phosphatidylcholine and sphingomyelin comprising the majority of the lipid fraction. Nucleotides, nucleosides, and purine-rich compounds (adenosine, guanosine derivatives) are present as bioactive constituents. Immunoglobulins and cytokine-inducing peptide fragments have been identified but not fully quantified in commercial extracts. Carbohydrate content is minimal (<5% dry weight), primarily as glycoproteins. Bioavailability of protein fractions depends heavily on processing method (lyophilization vs. heat extraction), with cold-process or freeze-dried extracts preserving more native peptide structures and biological activity compared to heat-processed preparations.

Preparation & Dosage

Animal studies have used 50 g/kg of porcine splenic hydrolysate in rat diets for 4 weeks, and 5-50 mg/kg body weight of PSP-5 immunopeptides in mice. No standardized human dosages have been established in clinical trials. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, Zinc, Astragalus, Beta-glucans, Reishi mushroom

Safety & Interactions

Porcine spleen extract is generally considered low-risk at standard supplemental doses, but individuals with pork or mammalian meat allergies face a meaningful risk of allergic reactions including urticaria or anaphylaxis. Theoretical interactions exist with immunosuppressant drugs such as cyclosporine or corticosteroids, as the extract's immune-stimulating properties could potentially counteract therapeutic immunosuppression. Pregnant and breastfeeding women should avoid use due to a complete absence of safety data in these populations, and individuals with autoimmune conditions such as lupus or rheumatoid arthritis should consult a physician before use due to unpredictable immune activation. Prion disease transmission risk, while considered low with modern manufacturing standards, has historically been a regulatory concern with all porcine glandular products.